ABT Abbott Labs: Net earnings per share for the last 12 months

ABT (Abbott Corp.) - company brandmark

Stable demand for infant formula and glucose sensors guarantees a predictable cash flow for Abbott Laboratories (ABT). Net income per share over the last 12 months visualizes this resilience, where 2.71 serves as the current parameter value. Profit growth is based on R&D leadership and the development of pacemakers, as well as the integration of digital services and wearable devices into a single health ecosystem.

ABT Abbott Corp. Net earnings per share for the last 12 months (07/04/2022 - 11/13/2026)

Financial and market metric breakdowns for Abbott Labs (ABT)

- stock price and consensus target price:
Stock Price Abbott Laboratories|ABT - Consensus Target
- company stock capitalization data:
Market Valuation Abbott Laboratories|ABT - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Net Assets per Single Share Abbott|ABT - Company Net Assets|Market Capitalization to Book Value Ratio abbott.com|ABT - Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Abbott Laboratories|ABT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Abbott Laboratories Inc.|ABT - Company Total Debt Obligations|Debts to Book Capitalization Abbott Laboratories|ABT - Company Long-Term Liabilities|Company Short-Term Debts Abbott|Quick Liquidity abbott.com
- earnings and multiples data:
ABT - Company Net Income|Future Profit Abbott Laboratories|ABT - Company Value to Net Income|Forward P/E Multiple Abbott|ABT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Abbott Laboratories|ABT - Operating profit before depreciation charges|Net earnings per share for the last 12 months Abbott|ABT - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth abbott.com|ABT - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Abbott Laboratories
Fundamental company analysis:Abbott Laboratories (ABT)
Manufactured products of Abbott Labs

Stable staffing and the retention of leading engineers at Abbott Laboratories (ABT) ensure technological continuity, which translates directly into sustainable profit growth. By analyzing the annual earnings per share trend, an investor sees the net profit over 12 months distributed across the total share issuance, allowing them to filter out market noise and assess the real efficiency of the business.

Competitor analysis

Thermo Fisher Scientific - Net earnings per share (EPS TTM)|gehealthcare.com (GEHC) - Net earnings per share for the last 12 months|MTD (Mettler Toledo) - Net earnings per share for the last 12 months|Waters Corp - Earnings per share for the trailing year|Earnings per share for the last twelve months Techne Corporation|Net earnings per share for the last 12 months Bruker BioSpin (BRKR)|Net earnings per share (EPS TTM) AZTA|VREX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) SMLR (Semler Scientific)|BFLY: Earnings per share for the last 12 months|Mesa Labs Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quantum-Si Corporation QSI|NNOX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months quanterix.com|MASS (908 Devices) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) CapsoVision Medical|Earnings per share for the last twelve months MaxCyte, Inc (MXCT)|Earnings per share for the last twelve months RPID (rapidmicrobio.com)|Seer, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year HYPR|FONAR - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Daxor Corporation|Spectral AI (MDAI) - Earnings per share for the last twelve months|Net earnings per share for the trailing year Organovo Holdings Inc. VIVS|Net earnings per share for the last 12 months ACON|Net earnings per share (EPS TTM) Akoya|Net earnings per share (EPS TTM) THMO|Net earnings per share for the last four quarters talis.bio|Earnings per share for the last twelve months T2 Biosystems, Inc TTOO